Log In
Print this Print this

GSK961081 (961081) (formerly TD-5959)

  Manage Alerts
Collapse Summary General Information
Company Innoviva Inc.
DescriptionBifunctional muscarinic receptor antagonist and beta 2 agonist (MABA)
Molecular Target Muscarinic receptor ; Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
PartnerGlaxoSmithKline plc;
Theravance Biopharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today